Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Aug;26(4):447-60.
doi: 10.1016/j.beem.2012.01.002. Epub 2012 May 22.

Subclinical hyperfunctioning pituitary adenomas: the silent tumors

Affiliations
Review

Subclinical hyperfunctioning pituitary adenomas: the silent tumors

Odelia Cooper et al. Best Pract Res Clin Endocrinol Metab. 2012 Aug.

Abstract

Pituitary adenomas are classified by function as defined by clinical symptoms and signs of hormone hypersecretion with subsequent confirmation on immunohistochemical staining. However, positive immunostaining for pituitary cell types has been shown for clinically nonfunctioning adenomas, and this entity is classified as silent functioning adenoma. Most common in these subtypes include silent gonadotroph adenomas, silent corticotroph adenomas and silent somatotroph adenomas. Less commonly, silent prolactinomas and thyrotrophinomas are encountered. Appropriate classification of these adenomas may affect follow-up care after surgical resection. Some silent adenomas such as silent corticotroph adenomas follow a more aggressive course, necessitating closer surveillance. Furthermore, knowledge of the immunostaining characteristics of silent adenomas may determine postoperative medical therapy. This article reviews the incidence, clinical behavior, and pathologic features of clinically silent pituitary adenomas.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare that there is no conflict of interest.

Figures

Figure 1
Figure 1
Model for development of human anterior pituitary cell lineage determination by a temporally controlled cascade of transcription factors. Trophic cells are depicted with transcriptions factors known to determine cell-specific human or murine gene expression. Adapted with permission from S. Melmed, J. Clin. Invest. 112:1603–1618 (2003). doi:10.1172/JCI200320401.

References

    1. Melmed S. Pathogenesis of pituitary tumors. Nat Rev Endocrinol. 2011;5:257–266. - PubMed
    1. Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK) Clin Endocrinol (Oxf) 2010;3:377–382. - PubMed
    1. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab. 2006;12:4769–4775. - PubMed
    1. Melmed S. Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest. 2003;11:1603–1618. - PMC - PubMed
    1. Levy A. Molecular and trophic mechanisms of tumorigenesis. Endocrinol Metab Clin North Am. 2008;1:23–50. vii. - PubMed

Publication types